Mycenax Biotech Free Cash Flow Generation Index

Latest as of March 2025: -4.90x

Mycenax Biotech free cash flow generation index. Mycenax Biotech (4726) has a Free Cash Flow Generation Index of -4.90x as of March 2025. Free cash flow of NT$-70.01 Million represents -5% of operating cash flow (NT$14.29 Million).

FCF Generation Index

-4.90x
Free Cash Flow / Operating CF

Free Cash Flow

NT$-70.01 Million
TWD

Operating Cash Flow

NT$14.29 Million
TWD

Capital Expenditures

NT$84.30 Million
TWD

Free Cash Flow Generation Index of Mycenax Biotech (2020–2020)

Free cash flow generation index of Mycenax Biotech from 2020 to 2020. Historical FCF Generation Index trend for Mycenax Biotech across 1 annual periods. See 4726 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Mycenax Biotech Free Cash Flow Generation Index by Year (2020–2020)

Mycenax Biotech free cash flow generation index by year from 2020 to 2020. Year-by-year Free Cash Flow Generation Index for Mycenax Biotech. For the full cash flow conversion analysis, see Mycenax Biotech operating cash flow efficiency.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2020 -0.51x NT$-88.09 Million NT$174.17 Million NT$260.22 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).